Literature DB >> 15703296

A shortened adeno-associated virus expression cassette for CFTR gene transfer to cystic fibrosis airway epithelia.

Lynda S Ostedgaard1, Tatiana Rokhlina, Philip H Karp, Philip Lashmit, Sandra Afione, Michael Schmidt, Joseph Zabner, Mark F Stinski, Jay A Chiorini, Michael J Welsh.   

Abstract

Adeno-associated viruses (AAVs) such as AAV5 that transduce airway epithelia from the apical surface are attractive vectors for gene transfer in cystic fibrosis (CF). However, their utility in CF has been limited because packaging of the insert becomes inefficient when its length exceeds approximately 4,900-5,000 bp. To partially circumvent this size constraint, we previously developed a CF transmembrane conductance regulator (CFTR) transgene that deleted a portion of the R domain (CFTRDeltaR). In this study, we focused on shortening the other elements in the AAV expression cassette. We found that portions of the CMV immediate/early (CMVie) enhancer/promoter could be deleted without abolishing activity. We also tested various intervening sequences, poly(A) signals, and an intron to develop an expression cassette that meets the size restrictions imposed by AAV. We then packaged these shortened elements with the CFTRDeltaR transgene into AAV5 and applied them to the apical surface of differentiated CF airway epithelia. Two to 4 weeks later, the AAV5 vectors partially corrected the CF Cl(-) transport defect. These results demonstrate that a single AAV vector can complement the CF defect in differentiated airway epithelia and thereby further the development of effective CF gene transfer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15703296      PMCID: PMC549485          DOI: 10.1073/pnas.0409845102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy.

Authors:  Z Yan; Y Zhang; D Duan; J F Engelhardt
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity.

Authors:  N Kaludov; K E Brown; R W Walters; J Zabner; J A Chiorini
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 3.  Gene therapy for cystic fibrosis.

Authors:  T R Flotte
Journal:  Curr Opin Mol Ther       Date:  1999-08

4.  Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors.

Authors:  C L Halbert; J M Allen; A D Miller
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

Review 5.  AAV-mediated gene transfer for hemophilia.

Authors:  K A High
Journal:  Ann N Y Acad Sci       Date:  2001-12       Impact factor: 5.691

6.  Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer.

Authors:  R W Walters; S M Yi; S Keshavjee; K E Brown; M J Welsh; J A Chiorini; J Zabner
Journal:  J Biol Chem       Date:  2001-03-21       Impact factor: 5.157

Review 7.  Integration of adeno-associated virus (AAV) and recombinant AAV vectors.

Authors:  Douglas M McCarty; Samuel M Young; R Jude Samulski
Journal:  Annu Rev Genet       Date:  2004       Impact factor: 16.830

8.  CFTR with a partially deleted R domain corrects the cystic fibrosis chloride transport defect in human airway epithelia in vitro and in mouse nasal mucosa in vivo.

Authors:  Lynda S Ostedgaard; Joseph Zabner; Daniel W Vermeer; Tatiana Rokhlina; Philip H Karp; Arlene A Stecenko; Christoph Randak; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

Review 9.  Gene therapy for cystic fibrosis.

Authors:  J C Davies; D M Geddes; E W Alton
Journal:  J Gene Med       Date:  2001 Sep-Oct       Impact factor: 4.565

10.  Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene.

Authors:  Christine L Halbert; James M Allen; A Dusty Miller
Journal:  Nat Biotechnol       Date:  2002-07       Impact factor: 54.908

View more
  34 in total

Review 1.  Genetic therapies for cystic fibrosis lung disease.

Authors:  Patrick L Sinn; Reshma M Anthony; Paul B McCray
Journal:  Hum Mol Genet       Date:  2011-03-21       Impact factor: 6.150

2.  Viral serotype and the transgene sequence influence overlapping adeno-associated viral (AAV) vector-mediated gene transfer in skeletal muscle.

Authors:  Arkasubhra Ghosh; Yongping Yue; Dongsheng Duan
Journal:  J Gene Med       Date:  2006-03       Impact factor: 4.565

3.  Cystic fibrosis transmembrane conductance regulator with a shortened R domain rescues the intestinal phenotype of CFTR-/- mice.

Authors:  Lynda S Ostedgaard; David K Meyerholz; Daniel W Vermeer; Philip H Karp; Lindsey Schneider; Curt D Sigmund; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-01       Impact factor: 11.205

4.  Directed evolution of adeno-associated virus to an infectious respiratory virus.

Authors:  Katherine J D A Excoffon; James T Koerber; David D Dickey; Matthew Murtha; Shaf Keshavjee; Brian K Kaspar; Joseph Zabner; David V Schaffer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

5.  Hoechst increases adeno-associated virus-mediated transgene expression in airway epithelia by inducing the cytomegalovirus promoter.

Authors:  David D Dickey; Katherine J D A Excoffon; Krista R Young; Kalpaj R Parekh; Joseph Zabner
Journal:  J Gene Med       Date:  2012-06       Impact factor: 4.565

6.  CFTR gene transfer with AAV improves early cystic fibrosis pig phenotypes.

Authors:  Benjamin Steines; David D Dickey; Jamie Bergen; Katherine Jda Excoffon; John R Weinstein; Xiaopeng Li; Ziying Yan; Mahmoud H Abou Alaiwa; Viral S Shah; Drake C Bouzek; Linda S Powers; Nicholas D Gansemer; Lynda S Ostedgaard; John F Engelhardt; David A Stoltz; Michael J Welsh; Patrick L Sinn; David V Schaffer; Joseph Zabner
Journal:  JCI Insight       Date:  2016-09-08

7.  Optimization of Recombinant Adeno-Associated Virus-Mediated Expression for Large Transgenes, Using a Synthetic Promoter and Tandem Array Enhancers.

Authors:  Ziying Yan; Xingshen Sun; Zehua Feng; Guiying Li; John T Fisher; Zoe A Stewart; John F Engelhardt
Journal:  Hum Gene Ther       Date:  2015-04-20       Impact factor: 5.695

8.  Generation of novel AAV variants by directed evolution for improved CFTR delivery to human ciliated airway epithelium.

Authors:  Wuping Li; Liqun Zhang; Jarrod S Johnson; Wu Zhijian; Joshua C Grieger; Xiao Ping-Jie; Lauren M Drouin; Mavis Agbandje-McKenna; Raymond J Pickles; R Jude Samulski
Journal:  Mol Ther       Date:  2009-07-14       Impact factor: 11.454

9.  Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys.

Authors:  Philip R Johnson; Bruce C Schnepp; Jianchao Zhang; Mary J Connell; Sean M Greene; Eloisa Yuste; Ronald C Desrosiers; K Reed Clark
Journal:  Nat Med       Date:  2009-05-17       Impact factor: 53.440

10.  Functional promoter testing using a modified lentiviral transfer vector.

Authors:  Scott F Geller; Phillip S Ge; Meike Visel; Kenneth P Greenberg; John G Flannery
Journal:  Mol Vis       Date:  2007-05-17       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.